Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shl Telemedicine ( (CH:SHLTN) ) has shared an update.
On September 16, 2025, SHL Telemedicine Ltd. held a Special General Meeting in Tel Aviv, where shareholders approved key resolutions including the repricing of options for CEO David Arnon and the granting of 100,000 options to Chairman Itamar Offer. These decisions reflect strategic moves to align executive incentives with company goals, potentially impacting SHL’s operational dynamics and stakeholder interests.
More about Shl Telemedicine
SHL Telemedicine is a leading provider and developer of advanced personal telemedicine solutions, focusing on cardiovascular and related diseases. The company offers personal telemedicine systems and medical call center services to end users and the healthcare community, utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange.
Average Trading Volume: 2,970
Current Market Cap: CHF23.84M
For an in-depth examination of SHLTN stock, go to TipRanks’ Overview page.